New Therapeutic Strategies in Nephrology: Proceedings of the 3rd International Meeting on Current Therapy in Nephrology Sorrento, Italy, May 27–30, 1990

Front Matter....Pages i-xxiii
Front Matter....Pages 1-1
Modulation of Endothelial Barrier and Coagulant Properties by Hypoxia....Pages 3-7
Cellular Immunity in Glomerular Pathology Primarily Induced by Immune-Complexes....Pages 8-18
Immunosuppressive Treatment of Autoimmune Nephropathies....Pages 19-24
Effect of Proteinase Inhibitor Camostat Mesilate on Nephrotic Syndrome....Pages 25-27
Treatment of Nephrotic Hyperlipidemia....Pages 28-30
Effect of PSK Administration Followed by Initial Prednisolone Therapy in the Steroid Responsive Idiopathic Nephrotic Children....Pages 31-33
Zinc Therapy for Minimal Change Nephrotic Syndrome and its Effect on IgG Synthesis....Pages 34-36
The Nephrotic Syndrome in the Elderly: Epidemiological Data....Pages 37-39
Antiaggregating Platelet Therapy in Chronic Glomerulone Phritis (GN)....Pages 40-42
Membranoproliferative Glomerulonephritis Type I: A Correlation Between Treated (138) and Untreated (108) Patients....Pages 43-45
Methylprednisolone (MP) Pulse Therapy in Childhood IgA Nephropathy....Pages 46-48
Immunosuppressive Treatment of Berger’s Disease....Pages 49-51
High Dose Intravenous Human IgG in the Treatment of Idiopathic Membranous Nephropathy: Preliminary Report of a Multicentric Trial....Pages 52-53
Treatment of Patients with Membranous Nephropathy(MN)....Pages 54-56
Anticoagulant Therapy and Steroid Pulse Therapy to Rapidly Progressive IgA Nephropathy....Pages 57-59
Contemporary Treatment of Idiopathic Membranous Glomerulonephritis....Pages 60-62
Effect of Methylprednisolone Pulse Therapy in Patients with Lupus Nephritis Assessed by who Morphologic Classification....Pages 63-65
Effect of Dilazep Dihydrochloride(DZ) Therapy in Patients with Chronic Glomerulonephritis....Pages 66-68
Follow-Up of Treated Patients with Primitive Membranous Nephritis....Pages 69-71
Role of ACE Inhibition in IgA Nephropathy....Pages 72-74
Front Matter....Pages 1-1
Early Indicators of Renal Disease in Parenteral Substance Abusers....Pages 75-77
Platelet derived growth factor and interleukin-1 expression are increased in murine IgA nephropathy....Pages 78-80
Effect of Cyclosporine a on the Anionic Sites in the Glomerular Basement Membrane of Puromycin Nephrotic Rats....Pages 81-83
Therapeutic Approach for the Deteriorated Renal Function in IgA Nephropathy....Pages 84-86
IgA Nephropathy and Cytomegalovirus....Pages 87-90
Intestinal Permeability and Antibodies Against Dietary Antigens in IgA Nephropathy....Pages 91-94
Parameters Affecting the Poor Prognosis of IgA Nephropathy — A Clinical Study —....Pages 95-97
Successful Induction of Seroconversion and Diminished Proteinuria in 3 Cases of Hepatitis B Virus (HBV) Associated Glomerulonephritis....Pages 98-100
Goodpasture’s Syndrome: A Clinic Case....Pages 101-103
Effects of Piretanide on Renal Function and the ANP/RAA-System in Patients with the Nephrotic Syndrome....Pages 104-106
Inhibition of the Hydroxyl Radical by Dimethylthiourea and Proteinuria in Adriamycin Experimental Nephrosis....Pages 107-110
Late Treatment with Captopril Worsens the Course of Adriamycin Nephropathy in Rats....Pages 111-114
Front Matter....Pages 115-115
Acute Renal Failure After Poisoning with Concentrated Acetic Acid....Pages 117-119
Daily Recycled Bicarbonate Dialysis in Treatment for Acute Renal Failure in Critically Ill Patients....Pages 120-122
Endotoxin Stimulates Synthesis of Platelet Activating Factor Via Production of Tumor Necrosis Factor by Human Mesangial Cells....Pages 123-126
Reversible Acute Renal Failure in Lupus Nephritis Due to a Hypertensive Crisis....Pages 127-130
Early Effects of Acute Obstruction of Biliary Duct in the Rat....Pages 131-133
Front Matter....Pages 135-135
Treatment of Hypertension in Chronic Renal Failure....Pages 137-141
Geographical Distribution of the Unknown Aetiology End-Stage Renal Failure in Greece....Pages 142-144
Valuation of the Immunological Parameters in Chronic Renal Insufficient Patients With or Without Haemodialytic Treatment....Pages 145-147
Front Matter....Pages 135-135
Chronic Renal Failure (CRF) and Lipidemic Parameters....Pages 148-150
The Effect of Cimetidine on Parathyroid in the Uremic Patients....Pages 151-153
Bone GLA Protein in Chronic Renal Failure....Pages 154-156
Cystic Diseases in Uremia and HLA System....Pages 157-159
Cardiac Morphology Evaluation in Patients with Chronic Renal Failure: An Echocardiography Study....Pages 160-162
ANP in Chronic Renal Failure is Related to Plasma Creatinine but not to Blood Pressure or Dialysis....Pages 163-165
Correlation of Biochemical and Histological Indices of Renal Osteodystrophy in Patients with Mild to Moderate Chronic Renal Failure....Pages 166-168
Does Indomethacin in Bartter’s Syndrome Interfere with the Membrane Receptors for GH?....Pages 169-171
Front Matter....Pages 173-173
Advanced Glycosylation End Products: Interactions with Cells....Pages 175-179
Antihypertensive Treatment and Evolution of Incipient Nephropathy in Type II Diabetic Patients. A 30 Month Follow Up....Pages 180-182
Beneficial Effect of Dipyridamole on Proteinuria in Diabetic Nephropathy....Pages 183-185
Renal Functional Reserve (RFR) in Patients with Short Term Type 1 Diabetes Mellitus (DM1) without Nephropathy....Pages 186-188
Diabetic Nephropathy: Prevalence and Risk Factors....Pages 189-191
The Terminal Complement Complex (TCC) in the Plasma of Patients with Type 1 Diabetes Mellitus. Relationship with Albumin Excretion Rate....Pages 192-193
Microalbuminuria and Renal Lesions in Diabetic Nephropathy....Pages 194-196
Effect of Dietary Protein Restriction on the Progression of Renal Damage in Diabetic Nephropathy....Pages 197-199
Diabetic Nephropathy in Outpatients with Type 2(Non Insulin-Dependent) Diabetes....Pages 200-202
Prevalence of Diabetic Nephropathy in a Single Region: Changes in Acceptance Rates in the Last 8 Years....Pages 203-205
Arterial Hypertension (AH) and Microalbuminuria (MA) in Patients with Type 2 Diabetes Mellitus....Pages 206-208
“Incipient” Nephropathy, Serum Apolipoproteins and Blood Pressure Levels in Type I Diabetes....Pages 209-211
Front Matter....Pages 173-173
ACE Inhibitors of Diabetic Nephrosis....Pages 212-213
Radioisotopical Studies of the Glomerular Filtrate in a Group of Insulin-Dependent Diabetics....Pages 214-217
Diabetic Nephropathy in Type 2(Non Insulin-Dependent) Diabetes: A Cross-Sectional Study....Pages 218-220
Front Matter....Pages 221-221
Nifedipine Versus Captopril in the Treatment of Severe Hypertension of Diabetic Patients....Pages 223-225
Effects of rHuEPO on the Aldosterone Secretion....Pages 226-228
Efficacy and Tolerability of Cilazapril (CLZ) in Hypertensive Patients (PTS) with Chronic Renal Failure (CRF)....Pages 229-231
Long Term Results of Renal Angioplasty in Patients with Renovascular Hypertension....Pages 232-234
Nitrendipine in Patients with End-Stage Renal Disease and Hypertension....Pages 235-237
First Choice Treatment of Dialysis-Resistant Hypertension: A Crossover Comparison of Single Oral Dose of Captopril and Nifedipine....Pages 238-240
Clinical Study of Bunazosin Treatment for Patients with Renal Hypertension....Pages 241-243
Vasodilatory Prostaglandins and Loop Diuretics....Pages 244-246
Systemic Hypertension in 5/6 Nephrectomized Rats Does Not Affect the Changes Caused by Low Protein Intake....Pages 247-249
Diltiazem: Its Antihypertensive Activity without Renal Effects in Man....Pages 250-252
Effects of Piretanide on Sodium and Potassium Excretion and on Renal Hemodynamics....Pages 253-256
Front Matter....Pages 257-257
How to Improve Biocompatibility in Dialysis....Pages 259-264
Captopril Treatment of Hypertensive Patients on Maintenance Hemodialysis....Pages 265-267
Importance of Volume Factors in Dialysis-Related Hypertension....Pages 268-270
Effects of Different Hemodialysis (HD) Methods on the Nutritional Status of HD Patients (PTS)....Pages 271-273
Urea Kinetic Parameters in Haemodialysis Patients Treated with Erythropoietin....Pages 274-276
Continuous Ambulatory Peritoneal Dialysis as an Alternative Therapy to Metal Removal with Desferrioxamine B....Pages 277-279
Front Matter....Pages 257-257
Endogenous Hyperphosphatemia in Patients Treated with Maintenance Hemodialysis....Pages 280-282
Prostacyclin in Haemodialysis....Pages 283-285
Atrial Natriuretic: Factor, B-Endorphin, Parathyroid Hormon and Recombinant Human Erythropoietin in Haemodialysis Patients.....Pages 286-288
Altered Membrane Transport of Choline in Renal Failure: A Comparison of Non-Dialysed and Haemodialysed Patients....Pages 289-291
Direct Inhibitory Effect of Intravenous Calcitriol on Parathyroid Function in Hemodialysis Patients....Pages 292-295
Maxillary “Giant Cell Brown Tumor” (GCBT) in a Patient on Maintenance Hemodialysis (HD) with Secondary Hyperparatyroidism (SHPT): Case Report....Pages 296-298
Prevention of Thrombosis of Vascular Prosthesis in Hemodialysis: Effect of Long-Term Treatment with Urokinase at the End of the Dialytic Session....Pages 299-301
Free Erythrocyte Protoporphyrin in Hemodialysis Patients Treated with Human Recombinant Erythropoietin....Pages 302-304
The Value of Desferrioxamine (DFO) Test in Accidental Acute Aluminum Overload in Hemodialysis. Six Months Later, the Influence of DFO Treatment....Pages 305-307
Comparative Efficacy of Two Different Intravenous Dosages of Recombinant Human Erythropoietin (rHuEPO) in the Anemia of Haemodialysis. Effects on Iron Stores.....Pages 308-310
Dialysis and Urine Flow....Pages 311-313
Bone Metabolism Parameters in Patients Undergoing Intravenous Calcitriol Treatment....Pages 314-316
Effect of Deferoxamine on Aluminum Kinetics During Hemodialysis....Pages 317-319
Is Zero Net Peritoneal Ultrafiltration (Net Uf) A Desirable Aim in Capd?....Pages 320-322
Could Secondary Hyperparathyroidism Influence the Response to Hepatitis B Vaccination of Hemodialyzed Patients?....Pages 323-324
Recombinant Human Erythropoietin R-HuEPO, Effective Treatment in Correction the Anemia of Patients in Hemodialysis (HD)....Pages 325-327
Anti-HCV in HD: A Preliminar Report....Pages 328-330
Effects of Hemodialysis on Cerebral Blood Velocity in Uremic Patients....Pages 331-334
Acetate Free Biofiltration (A.F.B.): 12 Months of Experience....Pages 335-337
Calcium Carbonate (CaCO3) as a Phosphate Binder in Patients on Renal Replacement Therapy....Pages 338-345
Front Matter....Pages 257-257
Classical and Alternative Pathway Complement Activity in Hemodialysis and CAPD Patients....Pages 346-348
Thrombotic Risk During r-EPO Therapy in Hemodialyzed Patients. A New Hypothesys....Pages 349-351
Improvement of Treatment Compatibility in Dialysis by Blood Volume Controled Ultrafiltration....Pages 352-354
Continuous Control of Blood Volume Changes During Hemodialysis and its Implication for the Determination of an Optimal Ultrafiltration-Rate....Pages 355-357
Computer Modulated Profile Haemodialysis (CMP-HD) and Vasoactive Hormones....Pages 358-360
Improvement of Paired Filtration Dialysis (PFD) for Optimum Removal of Small and Large Molecules....Pages 361-363
Paired Filtration Dialysis (PFD). Spanish Multicentric Study....Pages 364-368
Comparison of Effects of Erythropoietin (r-HuEPO) in Patients on Hemodiafiltration (HDF) Vs Conventional Hemodialysis (SD)....Pages 369-371
Continuous Ultrasonic Measurement of Whole Blood Protein Concentration for the Assessment of Relative Blood Volume Changes During Hemodialysis....Pages 372-374
Computer-Modulated Profile Hemodialysis (CMP-HD) Versus Standard Bicarbonate Hemodialysis (BIC-HD)....Pages 375-377
New Strategies Enhance the Role of Peritoneal Dialysis in Renal Replacement Therapy....Pages 378-380
“Steady-State Blood and Tissue Plasticizer Concentration: In Vivo Comparison Between Dop (DEHP) and Tot (TEHT)”....Pages 381-383
Paired Filtration Dialysis (PFD):Biocompatibility and Depurative Efficiency....Pages 384-386
Myoglobin (MYO) Removal by Highly Permeable Polymethyl Metacrylate (PMMA) in Rhabdomyolysis-Induced Acute Renal Failure (RH-ARF)....Pages 387-389
Bicarbonate and Calcium Kinetics During Paired Filtration Dialysis (PFD)....Pages 390-392
Front Matter....Pages 393-393
Continuous Ambulatory Peritoneal Dialysis (CAPD): The Treatment of Choice in Paediatric Chronic Renal Failure (CRF)....Pages 395-400
CAPD is Not The Best Treatment for Children with ESRD: A Retrospective Study of 23 Patients Who Received Both CAPD and Hemodialysis....Pages 401-406
Risk-Orientated Preparation of Uremic Children for Renal Transplantation....Pages 407-410
Growth in Children on Long-Term Dialysis....Pages 411-413
Carnitine (C) Metabolism in Renal Insufficient and Regular Hemodialyzed Children....Pages 414-417
Front Matter....Pages 419-419
What Dialysis is Best for Diabetic Patients — Hemodialysis or CAPD?....Pages 421-427
Peritoneal Versus Extra-Corporeal Dialysis for Diabetic Uremic Patients: Where Do We Stand in the Early Nineties?....Pages 428-436
Renal Replacement Therapy in Diabetic Patients....Pages 437-439
The Treatment of Uremic Diabetic Patients (UDP) in Piemonte (Dialysis and Transplantation Registry — RPDT): Survival Analysis....Pages 440-442
Diabetes and Renal Replacement Therapy in Italy: Mode of Treatment and Major Complications....Pages 443-445
Renal Transplantation (RT) in Diabetic Nephropathy (DN) in the 80’s Decade....Pages 446-448
Dialytic Treatment of Diabetic Patients with End-Stage Renal Failure: 17 Years of Experience....Pages 449-451
Analysis of a Cohort of Diabetics on Dialysis: Clinical and Rehabilitation Features Related to Dialysis Age....Pages 452-454
Relative Risk of Death in Diabetic and Non Diabetic Dialysis PTS: A Useful Marker of a Cohort Features....Pages 455-457
Chronic Complications in Diabetic Hemodialyzed Patients....Pages 458-460
Impedance Cardiographic Evaluation of the Central Hemodynamic in Diabetic Patients Treated with Maintenance Hemodialysis/HD/....Pages 461-463
A Single-Institution Experience in 15-Year Dialysis Treatment of Diabetic Patients....Pages 464-466
Front Matter....Pages 467-467
Monoclonal Antibodies OKT 3 in Resistant Acute Allograft Rejections Treatment....Pages 469-471
Pancreas Transplantation Today: Indications, Techniques, and Results in Over 160 Cases....Pages 472-479
Determination of Gamma Interferon and Neopterin Serum Levels for Graft Monitoring....Pages 480-482
Xenogeneic Transplantation: Immunologic Issues and Future Prospects....Pages 483-488
The Role of Fine Needle Aspiration Biopsy in the Diagnosis of Acute Rejection in Early and Late Post-Transplant Monitoring....Pages 489-491
Temporary Double-J Stenting of the Ureter Following Renal Transplantation....Pages 492-494
Acute Phase Response During Monoclonal Antibody Treatment — Relationship to Antimonoclonal Sensitization....Pages 495-497
Protective Effect of Calcium-Channel Blockers on the Cyclosporins (CyA)-Related Nephrotoxicity....Pages 498-500
Front Matter....Pages 467-467
Lipid and Apoprotein Profile in Renal Transplant Recipients....Pages 501-503
Thyroid Function After Renal Transplantation....Pages 504-506
Simultaneous Pancreas-Kidney Transplantation: Early Detection of Rejection by Amylasuria Determination....Pages 507-509
Echo Doppler Sonography of the Renal Allograft Acute Rejection....Pages 510-512
Renal Hemodynamic Effects of Short-Term Therapy with Low Doses of Cyclosporine a in Humans with Intact Kidneys....Pages 513-515
Modifications of Plasma Volume and ANF During Long-Term Administration of Cyclosporie....Pages 516-518
Clinical Implications of Unexpected High Glomerular Filtration Rate After Renal Transplantation....Pages 519-521
Influence of HLA-Class II on Graft Survival in Patients with Low Cyclosporine Doses....Pages 522-524
Recurrence of Focal Glomerular Sclerosis (FGS) Following Renal Transplantation....Pages 525-527
Back Matter....Pages 529-539